ALFA Finder
11:18 IST
BSE
Board Meeting Date
Acutaas Chemicals Board Meeting Date
Acutaas Chemicals scheduled a board meeting for July 24, 2026. The board will consider the unaudited financial results for the June 30, 2026 quarter.
Acutaas Chemicals Ltd
Acutaas Chemicals Ltd news stories on ALFA NewsRead the news →- Share price
- ₹3,916.90
- Market cap
- ₹32,068 Cr
- Revenue (annual)
- ₹1,339 Cr
- Net profit (annual)
- ₹356.3 Cr
- P/E (TTM)
- 73.0×Sector 43.8×
- Promoter holding
- 32.66%+0.00% QoQ
- FII holding
- 22.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 5Earnings Call 5Management Change 4Financial Results 3Results Update 2Capacity Expansion 2Business Update 2Board Meeting Date 2Annual General Meeting 2Share Pledge 1Regulatory Approval 1Production Started 1Patent 1Other Announcement 1Dividend 1Board Meeting Outcome 1Annual Report 1Acquisition 1
Time
36 announcements with these filters
20:16 IST
BSE
Management Change
Acutaas Chemicals Management Change
Acutaas Chemicals promoted Mr. Anurag Shukla to General Manager Operations & Unit Head. The designation as SMP took effect July 2, 2026.
19:03 IST
NSE
Merger & Restructuring
Acutaas Chemicals Merger & Restructuring Worth ₹5.83 Cr
Acutaas Chemicals Limited's subsidiary ACEPL issued shares to A.R.Z Pharma Ltd for ₹5.83 Crore. Consequently, the parent's stake in ACEPL reduced from 100% to 90%.
- Value
- ₹5.83 Cr
18:16 IST
BSE
Merger & Restructuring
Acutaas Chemicals Merger & Restructuring Worth ₹5.83 Cr
Acutaas Chemicals Ltd subsidiary ACEPL allotted shares worth ₹5.83 Crore to A.R.Z Pharma Ltd. Consequently, ACEPL ceased being wholly-owned, with the parent's stake diluting to 90%.
- Value
- ₹5.83 Cr
17:49 IST
BSE
Management Change
Acutaas Chemicals Management Change
Acutaas Chemicals Limited announced the resignation of Senior General Manager Trilok Vasant Sontakke. His departure, effective May 15, 2026, is cited due to personal reasons.
13:13 IST
NSE
Earnings Call
Acutaas Chemicals Earnings Call: Key Takeaways
Acutaas Chemicals delivered record FY26 results with Revenue of ₹13,394 Mn and PAT of ₹3,564 Mn, driven by expansion in pharmaceutical and semiconductor segments.